Bioventus (BVS) Change in Cash (2020 - 2026)

Bioventus' Change in Cash history runs 7 years deep, the most recent figure standing at -$15.4 million for Q1 2026.

• Quarterly Change in Cash rose 18.04% year-over-year to -$15.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.0 million (up 650.15% YoY) and the FY2025 annual result came in at $9.7 million, up 109.09% from the prior year.
• Change in Cash was -$15.4 million for Q1 2026 at Bioventus, down from $9.1 million in the prior quarter.
• Across five years, Change in Cash topped out at $15.3 million in Q2 2023 and bottomed at -$41.7 million in Q3 2022.
• A 5-year average of -$3.7 million and a median of -$2.5 million in 2022 frame the typical range for Change in Cash.
• Annual changes were most pronounced in 2022 — Change in Cash plunged 583.55% — and 2025, when it jumped 708.18%.
• Bioventus' Change in Cash stood at -$2.5 million in 2022, then surged by 498.31% to $10.1 million in 2023, then plunged by 114.72% to -$1.5 million in 2024, then soared by 708.18% to $9.1 million in 2025, then sank by 269.63% to -$15.4 million in 2026.
• Business Quant data shows BVS's Change in Cash at -$15.4 million in Q1 2026, $9.1 million in Q4 2025, and $9.3 million in Q3 2025.